Cargando…

Molecular remission at T cell level in patients with rheumatoid arthritis

While numerous disease-modifying anti-rheumatic drugs (DMARDs) have brought about a dramatic paradigm shift in the management of rheumatoid arthritis (RA), unmet needs remain, such as the small proportion of patients who achieve drug-free status. The aim of this study was to explore key molecules fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inamo, Jun, Suzuki, Katsuya, Takeshita, Masaru, Kondo, Yasushi, Okuzono, Yuumi, Koga, Keiko, Kassai, Yoshiaki, Takiguchi, Maiko, Kurisu, Rina, Yoshimura, Akihiko, Takeuchi, Tsutomu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371080/ https://www.ncbi.nlm.nih.gov/pubmed/34404865 http://dx.doi.org/10.1038/s41598-021-96300-z

Ejemplares similares

Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell
por: Takeshita, Masaru, et al.
Publicado: (2019)

Identification of novel genes associated with dysregulation of B cells in patients with primary Sjögren’s syndrome
por: Inamo, Jun, et al.
Publicado: (2020)

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission
por: Tasaki, Shinya, et al.
Publicado: (2018)

Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren’s syndrome
por: Tasaki, Shinya, et al.
Publicado: (2017)

Identification of definitive serum biomarkers associated with disease activity in primary Sjögren’s syndrome
por: Nishikawa, Ayumi, et al.
Publicado: (2016)

Significant association between joint ultrasonographic parameters and synovial inflammatory factors in rheumatoid arthritis
por: Kondo, Yasushi, et al.
Publicado: (2019)

Notch-mediated conversion of activated T cells into stem cell memory-like T cells for adoptive immunotherapy
por: Kondo, Taisuke, et al.
Publicado: (2017)

Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease
por: Akiyama, Mitsuhiro, et al.
Publicado: (2016)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
por: Kimura, Noriko, et al.
Publicado: (2019)

Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells
por: Kojima, Marenori, et al.
Publicado: (2023)

Tocilizumab monotherapy uncovered the role of the CCL22/17‐CCR4(+) Treg axis during remission of crescentic glomerulonephritis
por: Sakai, Ryota, et al.
Publicado: (2020)

Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis
por: Takeshita, Masaru, et al.
Publicado: (2016)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

CD14(bright)CD16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis
por: Tsukamoto, Masako, et al.
Publicado: (2017)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis
por: Saito, Shuntaro, et al.
Publicado: (2017)

Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis
por: Okuyama, Ayumi, et al.
Publicado: (2010)

Changes in the molecular profiles of large-vessel vasculitis treated with biological disease-modifying anti-rheumatic drugs and Janus kinase inhibitors
por: Matsumoto, Kotaro, et al.
Publicado: (2023)

Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients
por: Takeshita, Masaru, et al.
Publicado: (2022)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan
por: Takeuchi, Tsutomu, et al.
Publicado: (2015)

Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis
por: Oba, Koji, et al.
Publicado: (2017)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Overview of biotherapy in rheumatoid arthritis (RA)
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Differential Diagnosis of Inflammatory Arthritis from Musculoskeletal Ultrasound View
por: Kondo, Yasushi, et al.
Publicado: (2022)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Defining and characterizing sustained remission in patients with rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2017)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?
por: Sungur, Can M.
Publicado: (2021)

Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
por: Hèctor, Corominas, et al.
Publicado: (2020)

Regulatory and other rheumatoid factors in rheumatoid arthritis patients with active disease or in remission
por: Beduleva, Liubov, et al.
Publicado: (2021)

Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

What is the future of CCR5 antagonists in rheumatoid arthritis?
por: Takeuchi, Tsutomu, et al.
Publicado: (2012)

Remission or Not Remission, That’s the Question: Shedding Light on Remission and the Impact of Objective and Subjective Measures Reflecting Disease Activity in Rheumatoid Arthritis
por: Brkic, Alen, et al.
Publicado: (2022)

Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study
por: Tanaka, Yoshiya, et al.
Publicado: (2022)

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013)

Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission Criteria
por: Smolen, Josef S., et al.
Publicado: (2017)

Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
por: Kapral, Theresa, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1v47gguh95s97957t2b552qvup